PAYX
57
-2
EQT
57
-3
QCOM
55
-2
SJM
16
-3
KLAC
45
-4
DD
61
4
GOOG
69
-10
LEG
31
3
CMG
69
-3
PWR
71
-3
XEL
65
-2
INTC
49
16
GS
75
-4
VLO
42
2
ACN
70
5
PSA
58
5
DGX
48
-3
MAT
38
-3
AIG
47
6
DLTR
40
4
PAYX
57
-2
EQT
57
-3
QCOM
55
-2
SJM
16
-3
KLAC
45
-4
DD
61
4
GOOG
69
-10
LEG
31
3
CMG
69
-3
PWR
71
-3
XEL
65
-2
INTC
49
16
GS
75
-4
VLO
42
2
ACN
70
5
PSA
58
5
DGX
48
-3
MAT
38
-3
AIG
47
6
DLTR
40
4
Financhill
Back

RE/MAX Holdings 10K Form

Sell
45

RMAX
RE/MAX Holdings

Last Price:
11.24
Seasonality Move:
4.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RMAX News And Ratings

See the #1 stock for the next 7 days that we like better than RMAX

RMAX Financial Statistics

Sales & Book Value

Annual Sales: $325.67M
Cash Flow: $16.29M
Price / Cash Flow: 5.03
Annual Sales: $22.42
Price / Book: 0.52

Profitability

EPS (TTM): -0.53000
Net Income (TTM): $-9.59M
Gross Margin: $241.81M
Return on Equity: 0%
Return on Assets: -1.66%

RE/MAX Holdings Earnings Forecast

Key RE/MAX Holdings Financial Ratios

  • The Gross Profit Margin over the past 11 years for RMAX is 74.25%.
  • The Selling, General & Administrative Expenses for RMAX have been equal to 52.68% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -51.78% of Operating Income.
  • The Net Earning history of RMAX is -21.19% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 6 years.

RE/MAX Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Real Estate Management & Development
Sector: Real Estate
Current Symbol: RMAX
CUSIP: 75524W
Website: remax.com

Debt

Debt-to-Equity Ratio: 1.04
Current Ratio: 1.37
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 8.86

RMAX Technical Analysis vs Fundamental Analysis

Sell
45
RE/MAX Holdings (RMAX) is a Sell

Is RE/MAX Holdings a Buy or a Sell?

  • RE/MAX Holdings stock is rated a Sell
    The current RE/MAX Holdings [RMAX] share price is $11.68. The Score for RMAX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.